Radiomics in breast MRI: current progress toward clinical application in the era of artificial intelligence
- PMID: 34704213
- DOI: 10.1007/s11547-021-01423-y
Radiomics in breast MRI: current progress toward clinical application in the era of artificial intelligence
Abstract
Breast magnetic resonance imaging (MRI) is the most sensitive imaging modality for breast cancer diagnosis and is widely used clinically. Dynamic contrast-enhanced MRI is the basis for breast MRI, but ultrafast images, T2-weighted images, and diffusion-weighted images are also taken to improve the characteristics of the lesion. Such multiparametric MRI with numerous morphological and functional data poses new challenges to radiologists, and thus, new tools for reliable, reproducible, and high-volume quantitative assessments are warranted. In this context, radiomics, which is an emerging field of research involving the conversion of digital medical images into mineable data for clinical decision-making and outcome prediction, has been gaining ground in oncology. Recent development in artificial intelligence has promoted radiomics studies in various fields including breast cancer treatment and numerous studies have been conducted. However, radiomics has shown a translational gap in clinical practice, and many issues remain to be solved. In this review, we will outline the steps of radiomics workflow and investigate clinical application of radiomics focusing on breast MRI based on published literature, as well as current discussion about limitations and challenges in radiomics.
Keywords: Artificial intelligence; Breast; Deep learning; MRI; Machine learning; Radiomics.
© 2021. Italian Society of Medical Radiology.
References
-
- Gao Y, Heller SL (2020) Abbreviated and ultrafast breast MRI in clinical practice. Radiographics 40:1507–1527. https://doi.org/10.1148/rg.2020200006 - DOI - PubMed
-
- Kato E, Mori N, Mugikura S et al (2021) Value of ultrafast and standard dynamic contrast-enhanced magnetic resonance imaging in the evaluation of the presence and extension of residual disease after neoadjuvant chemotherapy in breast cancer. Jpn J Radiol. https://doi.org/10.1007/s11604-021-01110-y - DOI - PubMed - PMC
-
- Yamaguchi K, Nakazono T, Egashira R et al (2021) Maximum slope of ultrafast dynamic contrast-enhanced MRI of the breast: comparisons with prognostic factors of breast cancer. Jpn J Radiol 39:246–253. https://doi.org/10.1007/s11604-020-01049-6 - DOI - PubMed
-
- Mann RM, Cho N, Moy L (2019) Breast MRI: state of the art. Radiology 292:520–536. https://doi.org/10.1148/radiol.2019182947 - DOI - PubMed
-
- Meyer-Base A, Morra L, Tahmassebi A et al (2020) AI-enhanced diagnosis of challenging lesions in breast MRI: a methodology and application primer. J Magn Reson Imaging. https://doi.org/10.1002/jmri.27332 - DOI - PubMed - PMC
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous